Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease — Stella

Recruiting

Back to Alzheimer Disease trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

Baylor College of Medicine, Houston, Texas

Key details

Phase

Very early testing

Sponsor

Baylor College of Medicine

Collaborators

The Methodist Hospital Research Institute

Enrollment target

~52 participants

Started

February 2022

Primary completion

April 2026

Age range

55 Years – 85 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov